secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0000950170-24-020126
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical Q4 net sales up 19% to $76.3M; ICL sales +22%; FY2024 outlook $335-340M
--------------------------------------------------------------------------------

- Q4 net sales $76.3M (+19% YoY), ICL sales $74.6M (+22%), ICL units +19%.
- Q4 net income $7.8M ($0.16 EPS) vs $6.8M ($0.14 EPS); gross margin 79.6% vs 77.7%.
- FY2023 net sales $322.4M (+13%), net income $21.3M ($0.43 EPS) vs $39.7M ($0.80 EPS).
- Cash, cash equivalents and investments $232.4M, no debt; FY2024 net sales outlook $335-340M.
- China ICL sales grew 30% in Q4; EMEA up 18%; company affirms FY2024 sales outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/0000950170-24-020126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017024020126/staa-20240226.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-020126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer